These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


760 related items for PubMed ID: 27150044

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. folA thyA knockout E. coli as a suitable surrogate model for evaluation of antifolate sensitivity against PfDHFR-TS.
    Suwanakitti N, Talawanich Y, Vanichtanankul J, Taweechai S, Yuthavong Y, Kamchonwongpaisan S, Kongkasuriyachai D.
    Acta Trop; 2024 Oct; 258():107360. PubMed ID: 39142549
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of the activities of pyrimethamine analogs against Plasmodium vivax and Plasmodium falciparum dihydrofolate reductase-thymidylate synthase using in vitro enzyme inhibition and bacterial complementation assays.
    Bunyarataphan S, Leartsakulpanich U, Taweechai S, Tarnchompoo B, Kamchonwongpaisan S, Yuthavong Y.
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3631-7. PubMed ID: 16954316
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fitness effects of DHFR-TS mutations associated with pyrimethamine resistance in apicomplexan parasites.
    Fohl LM, Roos DS.
    Mol Microbiol; 2003 Nov; 50(4):1319-27. PubMed ID: 14622418
    [Abstract] [Full Text] [Related]

  • 11. Inducible knockdown of Plasmodium gene expression using the glmS ribozyme.
    Prommana P, Uthaipibull C, Wongsombat C, Kamchonwongpaisan S, Yuthavong Y, Knuepfer E, Holder AA, Shaw PJ.
    PLoS One; 2013 Nov; 8(8):e73783. PubMed ID: 24023691
    [Abstract] [Full Text] [Related]

  • 12. Recombinant Plasmodium falciparum dihydrofolate reductase-based in vitro screen for antifolate antimalarials.
    Brobey RK, Sano G, Itoh F, Aso K, Kimura M, Mitamura T, Horii T.
    Mol Biochem Parasitol; 1996 Oct 30; 81(2):225-37. PubMed ID: 8898337
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine.
    Wu Y, Kirkman LA, Wellems TE.
    Proc Natl Acad Sci U S A; 1996 Feb 06; 93(3):1130-4. PubMed ID: 8577727
    [Abstract] [Full Text] [Related]

  • 16. Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum.
    Wooden JM, Hartwell LH, Vasquez B, Sibley CH.
    Mol Biochem Parasitol; 1997 Mar 06; 85(1):25-40. PubMed ID: 9108546
    [Abstract] [Full Text] [Related]

  • 17. A novel Plasmodium falciparum expression system for assessing antifolate resistance caused by mutant P. vivax dihydrofolate reductase-thymidylate synthase.
    O'Neil MT, Korsinczky ML, Gresty KJ, Auliff A, Cheng Q.
    J Infect Dis; 2007 Aug 01; 196(3):467-74. PubMed ID: 17597462
    [Abstract] [Full Text] [Related]

  • 18. Antimalarial target vulnerability of the putative Plasmodium falciparum methionine synthase.
    Leela N, Prommana P, Kamchonwongpaisan S, Taechalertpaisarn T, Shaw PJ.
    PeerJ; 2024 Aug 01; 12():e16595. PubMed ID: 38239295
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 38.